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Abstract:
Background and Objective:
Metabolic syndrome (MetS) is associated with an increased risk of periodontitis even if the mechanism is unknown. Since both MetS
and periodontitis are characterized by an alteration of inflammation status, the aim of this pilot study was to determine if differences
in ROS metabolism of phagocytes isolated from (A) patients with MetS, (B) patients with both MetS and mild periodontitis, (C)
healthy subjects and (D) normal weight subjects with mild periodontitis, were present.
Methods:
ROS metabolism was studied by a Chemiluminescence (CL) technique: the system was made up of luminol (100 nmol/L) and cells
(1 × 105) in the presence or absence of stimulus constituted by opsonized zymosan (0.5 mg). The final volume (1.0 mL) was obtained
using modified KRP buffer. ROS production was measured at 25°C for 2 h, using an LB 953 luminometer (Berthold, EG & G Co,
Germany). All the experiments were performed in triplicate.
Statistical Analysis:
All results are mean ± standard deviation (SD). The group of means was compared by the analysis of variance "(ANOVA)". A value
of p < 0.05 was considered significant.
Results:
Results showed that basal ROS production (both from PMNs and from PBMs) of groups A, B and D was increased with respect to
that obtained from group C (p <0.05).
Conclusion:
These results are congruent with literature data, although the actual clinical relevance of the phenomenon remains to be evaluated.
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1. INTRODUCTION
Metabolic Syndrome (MetS) comprises a set of risk factors for cardiovascular disease and type 2 diabetes mellitus
[1,  2];  these risk factors are obesity,  impaired glucose tolerance,  hyperinsulinemia,  dyslipidemia,  pro-inflammatory
state, etc., [3]. In addition, recent clinical studies have provided evidence that MetS increases with age [4] and it, as well
as obesity is associated with an increased risk of periodontitis [5 - 9]. Since both obesity and MetS are characterized by
lipid metabolism disorders, it is possible to hypothesize that this alteration increases the risk of developing periodontal
disease [10], that is one of the most common chronic infection in the world [11]. In a recent paper [10], Li et al. showed
that MetS is associated with increased periodontal inflammation induced by lipopolysaccharide (LPS) in Zucker fat rats
(a model of MetS) with respect to control lean rats. In the same paper, the role of palmitic acid and LPS in periodontitis
is also reported. More generally, it is possible to assume that the association between obesity and periodontal diseases is
probably  based  on  the  effect  of  pro-inflammatory  cytokines  (i.e.Tumor  necrosis  factor-α-TNF-α-;granulocyte/
macrophage  colony-stimulating  factor-GM-CSF-,etc.)  released  by  adipose  tissue.
LPS –  as  well  as  pro-inflammatory  cytokines,  phorbol-12-myristate-13-acetate  (PMA),  and  N-formylmethionyl
leucyl  phenylalanine  (fMLP)  is  involved  in  Reactive  Oxygen  Species  (ROS)  production,  through  the  activation  of
p47phox  (a  subunit  of  NADPH  oxidases)  by  phosphorylation  catalyzed  by  Protein  Kinase  C  (PKC).  Membrane
NADPH oxidases  are  present  in  a  variety  of  cells  like  granulocyte  polymorphonucleates  (PMNs),  peripheral  blood
monocytes/macrophages (PBMs) system and endothelial cells [12].
The classical NADPH oxidase present in phagocytes consists of two membrane subunits (gp91phox and 22phox,
forming  flavocytochrome  b558  complex),  the  active  form  of  the  enzyme  is  obtained  when  the  cytosolic  subunits
p47phox, p40phox, p67phox, and Rac1 are activated and translocated to plasma membrane [13]. Only in the active
form, the enzyme is able to transfer electrons from NADPH to O2 forming O2
-. which is transformed into H2O2. PMNs
are able to transform H2O2 in HOCl by the enzyme myeloperoxidase [14].
To  explain  the  relationship  between  MetS,  inflammation  and  periodontitis,  the  aim  of  this  pilot  study  was  to
determine  if  differences  in  ROS  metabolism  of  phagocytes  isolated  from  (A)  obese  patients  with  MetS  (B)  obese
patients  with  both  MetS  and  mild  periodontitis,  (C)  healthy  subjects  and  (D)  normal  weight  subjects  with  mild
periodontitis, were present.
This type of study, which analyzes the systemic basis of oral cavity pathologies,  is becoming more common as
scientists  are  interested  in  the  dental  field  [15]  and  in  the  multidisciplinary  approach  required  in  the  treatment  of
patients with special needs [16]. This is because of the spread of new and sensitive techniques for the diagnosis of oral
cavity pathologies [17].
2. MATERIALS AND METHODS
2.1. Patients
The sample of this pilot study was made up of four different groups (A, B, C, D):
Group A involved 2 MetS obese patients without any form of periodontal disease.
Group B involved 2 MetS obese patients with a mild form of periodontal disease.
Group C included 4 normal weight subjects without any form of periodontal disease.
Group D included 3 normal weight patients with a mild form of periodontal disease.
Patients belonging to groups A and B were consecutive patients admitted to the department of internal medicine of
“Fondazione Policlinico Universitario Agostino Gemelli” teaching hospital to keep their obesity status under control
with regular blood tests and specialist visits. They were selected according to the following inclusion criteria: over 40
years of age, Body Mass Index (BMI) over 40, absence of diabetes or any cardiac disease, and non-smokers or ex-
smokers for more than 10 years. Patients who formed groups C and D were consecutive patients attending the dentistry
institute  of  “Fondazione  Policlinico  Universitario  Agostino  Gemelli”  teaching  hospital  for  dental  check-ups  and
treatments. Among these, 7 patients with age between 40 and 55, with the absence of diabetes or any cardiac disease,
BMI lower than 30 and non-smoker or ex-smokers for more than 10 years were selected. In order to avoid confounding
effects of ulcerative-erosive lesions of oral mucosa [18], benign [19, 20] and malignant [21] neoplasms, cystic lesions
[22] and immunological diseases [23] on immunoinflammatory and hormonal response patients were selected in the
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absence of such conditions. For this purpose, patients underwent a clinical and radiographic dental check-up before
inclusion in the present study. None of the study participants had received in the previous two months any steroidal or
immunosuppressive drug which could influence immune and hormonal response. The study was conducted according to
the  1975 Helsinki  Declaration,  as  revised  in  2000 and  underwent  local  Ethics  Committee  evaluation  (“Fondazione
Policlinico Gemelli” Prot. N°0027002/17); written informed consent was obtained from every patient. Blood samples
were collected in fertile women during the follicular phase. All patients (4 female and 7 male) underwent a periodontal
examination in which Periodontal Screening and Recording (PSR) was performed. Patients were divided according to
the periodontal status following the results of the PSR: codes 0-1-2 were considered as a state of general periodontal
health whereas code 3 was associated to a mild form of periodontal disease. Only patients with homogenous  PSR codes
in  all sextants  were included.  Based on BMI,  patients  were  divided  into  obese (BMI > 40)  or normal weight  (BMI
< 30). Demographic  characteristics of  patients included in this  study are presented in Table 1.
Table 1. Demographic characteristics of patients included in this study.
Sex Age (years) BMI (kg/m2) PSRCode Systemic Diseases Smoking Habits Group
Patient 1 F 45 44,4 0 Absence Absence A
Patient 2 M 54 42,3 1 Absence Ex-smoker A
Patient 3 M 43 45,1 3 Absence Absence B
Patient 4 F 44 41,4 3 Absence Absence B
Patient 5 M 55 24,9 0 Absence Absence C
Patient 6 F 52 23,2 1 Absence Absence C
Patient 7 M 50 22,9 0 Absence Absence C
Patient 8 M 50 25,3 0 Absence Ex-smoker C
Patient 9 F 51 21,1 3 Absence Absence D
Patient 10 M 49 24,9 3 Absence Ex-smoker D
Patient 11 M 58 23,3 3 Absence Ex-smoker D
F = female; M = male
2.2. Polymorphonucleocytes (PMNs) Isolation
Venous blood (10 mL), obtained from each volunteers, was diluted with physiological solution (10 mL). Dextran in
physiological solution (6%, 4 mL) was then added to enhance the sedimentation rate of erythrocytes at 1 × g. After 30
min,  the  white  blood  cells  suspension  was  centrifuged  on  Lymphoprep  (Pharmacia,  Sweden),  according  to  the
manufacturer’s instructions, to remove the contaminating mononuclear cells, and finally the pellet underwent hypotonic
lysis  to  remove  erythrocytes.  The  recovered  PMNs  were  washed  three  times  and  resuspended  in  Krebs  Ringer
phosphate  (KRP)  solution  (200.000/mL,  pH  7,  4).
2.3. Peripheral Blood Monocytes (PBMs) Isolation
Lympho-monocytes were isolated through lymphoprep (Pharmacia, Sweden) density gradient centrifugation.
Lympho-monocytes,  suspended  in  DMEM  (Dulbecco’s  modified  Eagle  medium)  with  HEPES  (10  mmol/L),
glucose (1.0 g/L), NaHCO3 (3.7 g/L), penicillin (100 Units/mL), streptomycin (100 μg/mL) and 10% Fetal Calf Serum
(1 × 106 cells/mL), were put into luminometer vials to allow the adhesion (37°C, 5% CO2 humidified atmosphere, 1 h).
Non-adhered cells were then gently removed by three washes with modified Krebbs–Ringer phosphate (KRP) buffer
and counted by Nucleocounter (Sartorius Stedim S.P.A, Firenze, Italy) to calculate, by subtraction from the whole, the
number of adhered cells [14]: the latter were mainly monocytes (> 90%), as determined using the aspecific esterase test,
a typical monocyte enzyme [24].
2.4. ROS Metabolism of Leukocytes
ROS metabolism was studied by a Chemiluminescence (CL) technique: the system was made up of luminol (5-
amino-2,3-dihydro-1,4-  phthalazindione,  100  nmol/L)  and  cells  (1  ×  105)  in  the  presence  or  absence  of  stimulus
constituted by or 150 nmol/L of phorbol 12-myristate 13-acetate (PMA) [24]. The final volume (1.0 mL) was obtained
using modified KRP buffer. ROS production was measured at 25°C for 2 h, using an LB 953 luminometer (Berthold,
EG&G Co, Germany). All the experiments were performed in triplicate.
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2.5. Statistical Analysis
All the results are expressed as mean ± standard deviation (SD). The group of means was compared by the analysis
of variance "(ANOVA)", followed when appropriate by a multiple comparison of means by Student-Newman-Keulz
test. A value of p < 0.05 was considered significant.
3. RESULTS
PMNs and PBMs isolated from all the subjects involving in this pilot study showed a similar oxidative burst (Figs.
1A and 1B). In fact, no statistical differences were observed among the four groups.
Fig. (1). panel A CL integral (0-2 h) of PMNs in presence or absence of PMA; Panel B CL integral (0-2 h) of unstimulated PMNs.
*p< 0.05**p < 0.01; ***p < 0.001.
On the contrary, when unstimulated ROS production was considered, group C (normal weight subjects without any
form of periodontal disease) showed a statically reduced production of ROS with respect to all the other three groups
(Figs. 2A and 2B).
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Fig.  (2).  panel  A  CL  integral  (0-2  h)  of  PBMs  in  presence  or  absence  of  PMA;  Panel  B  CL  integral  (0-2  h)  of  unstimulated
PBMs.**p < 0.01.
4. DISCUSSION
It is well-known that both MetS and periodontitis are related to pro-inflammatory cytokines production. Among
other  functions,  these molecules are able to active p47phox and,  consequently,  the membrane NADPH oxidase,  an
enzyme present on the plasmatic membranes of PMNs and PBMs with the aim to initiate ROS production.
ROS  are  strong  oxidative  molecules  involved  in  inflammation  process  as  well  as  in  chronic  diseases,  but  at  -
physiological concentrations, they act as second messengers to regulate mitosis, apoptosis, cell differentiation, etc.,
[13]. Therefore the need to control the amount of ROS produced by NADPH oxidase is evident.
Since  ROS  production  is  involved  both  in  MetS  and  periodontitis,  the  results  obtained  in  this  pilot  study  are
intriguing and they deserve to be further evaluated.
In fact, we observed that the basal ROS production in PMNs and PBMs, isolated from groups A, B and D with
respect  to  normal  weight  subjects  without  any  form  of  periodontal  disease  (group  C)  statistically  increased.  This
phenomenon,  although not  unexpected,  is  interesting  and could  help  to  explain  the  relationship  between MetS and
severity of periodontitis observed by Li et al. [10].
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Only patients with mild form of periodontal disease were involved.
This methodological choice was dictated by the will of the authors to study the molecules involved in the onset of
periodontal  disease.  Li  et  al.  [10]  demonstrated  that  in  mice,  metabolic  syndrome provides  an  enhancement  of  the
destructive effects of periodontitis, but until now there have been no studies in literature investigating such association
with humans by evaluating the ROS involvement or hypothesizing the action of other molecules.
A substantial limitation of this study is that the sample of recruited patients is quite small since, in order to avoid
any confounding factor,  patients  suffering  from chronic  inflammatory  or  autoimmune diseases,  cystic,  benign,  and
malignant lesions in oral cavity or who underwent surgical interventions were excluded. For the same reason, patients
with  type  2  diabetes  mellitus  were  not  considered;  since  the  majority  of  patients  affected  by  metabolic  syndrome
quickly  develop  insulin  resistance  and  type  2  diabetes  mellitus  is  easy  to  understand  that  this  exclusion  criterion
strongly compressed the sample size.
CONCLUSION
Obviously  a  study  with  few  patients,  like  this,  cannot  provide  conclusive  results.  However,  it  has  provided
indications that can be confirmed by recruiting many more patients who should be strictly homogeneous from a medical
and dental point of view in order to avoid selection bias that could lead to not accurate conclusions.
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